FYR Diagnostics develops biomarker detection technology to combat chronic diseases in both human healthcare and agriculture.
FYR Diagnostics has raised $8.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
FYR Diagnostics's investors include National Science Foundation, Two Bear Capital, Yuvaan Tiwari Foundation, Sontag Innovation Fund, Mike Goguen.
FYR Diagnostics is headquartered in Missoula, United States.
FYR Diagnostics develops biomarker detection technology to combat chronic diseases in both human healthcare and agriculture.
FYR Diagnostics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"FYR Diagnostics — Funding & Investors." VCBacked, September 24, 2025, https://www.vcbacked.co/company/fyr-diagnostics. Accessed September 30, 2026.
VCBacked. (2025). FYR Diagnostics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/fyr-diagnostics
{{cite web |title=FYR Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/fyr-diagnostics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated